Literature DB >> 17393234

Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients.

Yeon-Ah Lee1, Jung Yeon Kim2, Seung-Jae Hong1, Sang-Hoon Lee3, Myung Chul Yoo4, Kyoung Soo Kim5, Hyung-In Yang6.   

Abstract

This study was performed to investigate whether synovial proliferation (SP) differentially affects hypoxia in the joint cavities of rheumatoid arthritis (RA) and osteoarthritis (OA) patients. Thirty RA and 42 OA patients who underwent synovitis assessment were classified into two groups based on the presence or absence of SP, as revealed by musculoskeletal ultrasonography. Synovial fluids (SFs) from the knee joints were analyzed for interleukin (IL)-8, pO(2), and white blood cell counts and blood samples were analyzed for erythrocyte sedimentation rate (ESR). No difference was found between the OA patients with and without SP in terms of SF oxygen tension (SF pO(2)) or IL-8 level, whereas the RA patients had significantly lower SF pO(2) levels in their knee joints than did the OA patients with SP, and the RA patients had higher levels of IL-8 in their joints than did the OA patients. The counts of infiltrated immune cells in the SF and tissues were much higher for patients with RA and SP than for those with OA and SP. The ESRs were not found to be correlated with SP in OA patients but were negatively correlated with SF pO(2) levels in RA patients. We conclude that ultrasonographically detected SP in OA patients does not generate a more hypoxic SF than that found in OA patients without SP. The SFs from RA patients with SP are hypoxic, which indicates that SP may have different impacts on hypoxia in the joint cavities of RA and OA patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393234     DOI: 10.1007/s10067-007-0605-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

Review 1.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 2.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

3.  High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein.

Authors:  G Hartmann; M Tschöp; R Fischer; C Bidlingmaier; R Riepl; K Tschöp; H Hautmann; S Endres; M Toepfer
Journal:  Cytokine       Date:  2000-03       Impact factor: 3.861

4.  Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis.

Authors:  K H Falchuk; E J Goetzl; J P Kulka
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

5.  C-reactive protein is related to impaired oxygenation in patients with acute aortic dissection.

Authors:  Kimiaki Komukai; Takahiro Shibata; Seibu Mochizuki
Journal:  Int Heart J       Date:  2005-09       Impact factor: 1.862

6.  Upregulation of interleukin-8 by hypoxia in human ovaries.

Authors:  Osamu Yoshino; Yutaka Osuga; Kaori Koga; Yasushi Hirota; Tetsu Yano; Osamu Tsutsumi; Akihisa Fujimoto; Koji Kugu; Mikio Momoeda; Toshihiro Fujiwara; Yuji Taketani
Journal:  Am J Reprod Immunol       Date:  2003-10       Impact factor: 3.886

Review 7.  Acute-phase proteins in osteoarthritis.

Authors:  J D Sipe
Journal:  Semin Arthritis Rheum       Date:  1995-10       Impact factor: 5.532

Review 8.  The value of C-reactive protein measurement in rheumatoid arthritis.

Authors:  I G Otterness
Journal:  Semin Arthritis Rheum       Date:  1994-10       Impact factor: 5.532

9.  Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages.

Authors:  Ellen Knutsen Rydberg; Linda Salomonsson; Lillemor Mattsson Hultén; Kristina Norén; Göran Bondjers; Olov Wiklund; Tom Björnheden; Bertil G Ohlsson
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

Review 10.  Oxidation in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

View more
  14 in total

Review 1.  Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Sofia Konisti; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.

Authors:  Yao Yao; Cong-zhu Ding; Yun Fang
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

3.  PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial-mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis.

Authors:  Guo-Qing Li; Yu Zhang; Dan Liu; Ya-Yun Qian; Hua Zhang; Shi-Yu Guo; Masataka Sunagawa; Tadashi Hisamitsu; Yan-Qing Liu
Journal:  Mol Cell Biochem       Date:  2012-09-23       Impact factor: 3.396

4.  A review on angiogenesis and its assays.

Authors:  Zoya Tahergorabi; Majid Khazaei
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

5.  Chondrogenic differentiation of human subchondral progenitor cells is affected by synovial fluid from donors with osteoarthritis or rheumatoid arthritis.

Authors:  Jan Philipp Krüger; Michaela Endres; Katja Neumann; Bruno Stuhlmüller; Lars Morawietz; Thomas Häupl; Christian Kaps
Journal:  J Orthop Surg Res       Date:  2012-03-13       Impact factor: 2.359

Review 6.  Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.

Authors:  Barbara Muz; Moddasar N Khan; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-01-20       Impact factor: 5.156

7.  Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models.

Authors:  Jun Soo Bang; Da Hee Oh; Hyun Mi Choi; Bong-Jun Sur; Sung-Jig Lim; Jung Yeon Kim; Hyung-In Yang; Myung Chul Yoo; Dae-Hyun Hahm; Kyoung Soo Kim
Journal:  Arthritis Res Ther       Date:  2009-03-30       Impact factor: 5.156

8.  Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.

Authors:  Nathalie Busso; Mahir Karababa; Massimo Nobile; Aline Rolaz; Frédéric Van Gool; Mara Galli; Oberdan Leo; Alexander So; Thibaut De Smedt
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

Review 9.  Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias
Journal:  Front Pharmacol       Date:  2016-06-27       Impact factor: 5.810

10.  Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis.

Authors:  Ken Yoshida; Haruyasu Ito; Kazuhiro Furuya; Taro Ukichi; Kentaro Noda; Daitaro Kurosaka
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.